Evidence map›Paper›PMID 32957392›Full record

ArticleMedicine2020

Endoscopic findings of gastric mixed adenoneuroendocrine carcinoma: A case report.

Keitaro Takahashi, Mikihiro Fujiya, Takahiro Sasaki, Yuya Sugiyama, Yuki Murakami, Takuya Iwama, Takehito Kunogi, Katsuyoshi Ando, Nobuhiro Ueno, Shin Kashima and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Keitaro TakahashiDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Mikihiro FujiyaDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Takahiro SasakiDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Yuya SugiyamaDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Yuki MurakamiDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Takuya IwamaDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Takehito KunogiDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Katsuyoshi AndoDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Nobuhiro UenoDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Shin KashimaDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Kentaro MoriichiDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Hiroki TanabeDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Sayaka YuzawaDepartment of Diagnostic Pathology, Asahikawa Medical University, Asahikawa, Japan.
Hidehiro TakeiDepartment of Diagnostic Pathology, Asahikawa Medical University, Asahikawa, Japan.
Toshikatsu OkumuraDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University.
Asahikawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleGastric mixed adenoneuroendocrine carcinoma (gMANEC) is a rare malignant tumor. Most gMANECs are diagnosed at an advanced stage and have a worse prognosis than gastric adenocarcinoma. In order to improve the prognosis, it is necessary to diagnose gMANEC at an early stage. However, the endoscopic features of early gMANECs are unclear. We, herein, report a case of early gMANEC that showed characteristic magnifying endoscopic findings. PATIENT CONCERNS: A 78-year-old man was referred to our institution for endoscopic resection of a gastric lesion. He had a medical history of distal gastrectomy due to early gastric cancer with negative surgical margins 9 years previously. DIAGNOSIS: Esophagogastroduodenoscopy showed a reddish depressed lesion on the suture line of the gastric remnant, which was classified as type 0-IIc according to the Paris classification. ME-NBI at the oral side of the lesion revealed the absence of the microsurface pattern (MSP) and scattered microvessels with dilation and caliber variation, while ME-NBI at the anal side showed an irregularly tubular MSP. An endoscopic forceps biopsy showed a well- to moderately differentiated adenocarcinoma.

interventionsWe performed endoscopic submucosal dissection, and en bloc resection of the tumor was successfully achieved. OUTCOMES: The histological findings showed two distinct components: neuroendocrine carcinoma (NEC) and well-differentiated adenocarcinoma, which comprised ∼60% and 40% of the tumor, respectively. The NEC component corresponded to the site with the absence of an MSP and scattered microvessels on ME-NBI, while the well-differentiated adenocarcinoma component corresponded to the site with an irregularly tubular MSP. The pathological diagnosis was mixed adenoneuroendocrine carcinoma, infiltrating into the deep submucosal layer. LESSONS: We propose that the absence of an MSP plus an irregular MSP is characteristics of gMANEC, which was useful for the diagnosis of gMANEC before treatment.

Indexed as

AgedCarcinoma, NeuroendocrineEndoscopy, Digestive SystemFemaleHumansMaleMiddle AgedNeoplasm InvasivenessStomach Neoplasms

Identifiers

PMID32957392
PMCPMC7505296
OpenAlexW3087620848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.